$HOLX News

Last published 7mo ago

7mo agoHOLXBlackstone and TPG Complete Acquisition of HologicBusiness WireAccomplished MedTech leader Joe Almeida named Chief Executive Officer Hologic, Inc. (NASDAQ:HOLX), a global leader in women's health, today announced the completion of its acquisition by funds managed by Blackstone
7mo agoHOLXHologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private TransactionBusiness WireHologic, Inc. (NASDAQ:HOLX) announced today that Steve MacMillan, its long-time Chairman, President and Chief Executive Officer (CEO), has decided to retire when the Company's go-private transaction with Blackstone and
7mo agoHOLX1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening RatesBusiness WireFifth edition of Hologic Global Women's Health Index reveals over half of women worldwide weren't tested for key conditions in the past year Hologic and Gallup convene experts to discuss closing gaps in screening
9mo agoHOLXHologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health PortfolioBusiness WireExpanded FDA approval across multiple cervical cancer screening modalities supports clinical flexibility and provider choice Hologic, Inc. (NASDAQ:HOLX) announced today that its Aptima® HPV Assay received FDA
9mo agoHOLXHologic Announces Financial Results for First Quarter of Fiscal 2026Business Wire– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases (9.2%), Non-GAAP Diluted EPS of $1.04 Up 1.0% – Hologic, Inc. (NASDAQ:HOLX) announced today the Company's financial results for the
9mo agoBFLY HOLX GEHC HYPRBedside Breakthrough: AI Brings MRI-Precision to Every ClinicPR NewswireThe medical imaging world is hitting a massive reset button as AI-driven clinical intelligence transforms how we map the human heart. With the...
10mo agoONCY EXAS VCYT HOLX+1Smart Oncology: 5 Stocks Chasing the $317B PrizePR NewswireThe precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035[1], driven by a fundamental shift in...
11mo agoHOLXHologic's AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening ExamsBusiness WireRetrospective analysis at top-tier medical facility highlights AI solution's ability to help spot previously missed cancers and correctly localize suspicious areas on mammograms Hologic, Inc. (NASDAQ:HOLX), a leading
11mo agoHOLXNew Clinical Evidence on Hologic's AI-Powered Mammography Solutions Will Be Unveiled at RSNABusiness WireStudies demonstrate AI's potential to streamline radiologists' workflows while upholding high sensitivity in detecting cancer New data on Hologic's (NASDAQ:HOLX) breast cancer detection technologies will be presented
12mo agoHOLXHologic Introduces Digital Pathology Capabilities With Expanded CE MarkingBusiness WireThe Genius Digital Diagnostics System now offers European labs the ability to streamline digital pathology workflows using one complete solution for a variety of specimen types Hologic, Inc. (NASDAQ:HOLX) announced
1y agoHOLXHologic Announces Financial Results for Fourth Quarter of Fiscal 2025Business Wire– Revenue of $1,049.5 Million Grows 6.2% – – GAAP Diluted EPS of $0.83 Increases 9.2%, Non-GAAP Diluted EPS of $1.13 Up 11.9% – Hologic, Inc. (NASDAQ:HOLX) announced today the Company's financial results for the
1y agoHOLXHOLX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Hologic to Blackstone and TPGGlobeNewswireMONSEY, N.Y., Oct. 29, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Hologic Inc. (NASDAQ:HOLX) ("Hologic") to Blackstone and TPG for an upfront
1y agoHOLXHologic to be Acquired by Blackstone and TPG for up to $79 per ShareBusiness WireHologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achieving Certain Revenue Milestones Represents 46% Premium to Hologic's Closing Price on Last
1y agoHOLX GEHC NNOX ORCLInvestors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion MarketPR NewswireArtificial intelligence (AI) is making inroads into every corner of medical technology, perhaps none more urgently than imaging. In breast cancer...
1y agoHOLXHologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025Business WireHologic, Inc. (NASDAQ:HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2025 on Monday, November 3, after the market closes. In conjunction with the release,
1y agoHOLXHologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious GastroenteritisBusiness WireNew Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays deliver tailored, actionable diagnostic results to support fast and informed patient care Hologic, Inc. (NASDAQ:HOLX) announced today that
1y agoHOLXNew Survey Results Underscore the Need to #BustTheMyth About MammogramsBusiness WirePoll of over 1,100 women shows that misconceptions around breast cancer remain a major barrier to potentially lifesaving screenings Global women's health leader Hologic, Inc. (NASDAQ:HOLX) will mark the start of
1y agoVNRX HOLXVolition Signs Co-Marketing and Services Agreement with HologicPR NewswireVolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with...
1y agoHOLXMinicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-ArmPR NewswireMinicarm.com, a leading provider of imaging solutions for orthopedic and surgical practices, is proud to announce that it has secured an allocation...
1y agoHOLXNew Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBIBusiness WireResearch suggests AI may help identify more aggressive breast cancers and perform comparably to experts in breast cancer screening
1y agoHOLXHologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
1y agoHOLXHologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare ConferenceBusiness WireHologic, Inc. (NASDAQ:HOLX) announced today that the Company will present at the 23rd Annual Morgan Stanley Global Healthcare Conference in New York at 10:45 a.m. Eastern Time on Tuesday, September 9th. The fireside
1y agoHOLXHologic, Inc. (HOLX) Q3 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoHOLXHologic Announces Financial Results for Third Quarter of Fiscal 2025Business Wire– Revenue of $1,023.8 Million Exceeds Guidance – – Company Reports GAAP Diluted EPS of $0.86; Non-GAAP Diluted EPS of $1.08 Exceeds Guidance – – In Fourth Quarter, Company Remains on Track for Solid Revenue Growth
1y agoHOLXHologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025Business WireHologic, Inc. (NASDAQ:HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2025 on Wednesday, July 30, after the market closes. In conjunction with the release,
1y agoHOLXHologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to PatientsBusiness WireCompleted assessment of more than 2,800 patients highlights the profound impact of the test in helping to predict the likelihood of extended endocrine therapy benefit for patients with HR+ breast cancer to support more
1y agoHOLXHologic Announces Financial Results for Second Quarter of Fiscal 2025Business Wire– Revenue of $1,005.3 Million Slightly Exceeds Guidance – – Company Reports GAAP Diluted EPS of ($0.08); Non-GAAP Diluted EPS of $1.03 at High End of Guidance – – Company Maintains Annual Revenue Guidance, Lowers
1y agoHOLXGroundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBIBusiness WireMGH-led study retrospectively analyzed 5,000 radiologist-reviewed screening exams using the company's Genius AI® Detection Solution Hologic, Inc. (NASDAQ:HOLX) will have a strong presence at the Society of Breast
1y agoHOLXHologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability ReportBusiness WireReport highlights efforts to enhance access and equity in women's health and invest in the future with science-based environmental targets, employee development and community engagement Hologic, Inc. (NASDAQ:HOLX),
1y agoHOLXWayde McMillan Elected to Hologic Board of DirectorsBusiness WireHologic, Inc. (NASDAQ:HOLX) announced today that Wayde McMillan has been elected to the Company's Board of Directors, effective April 4, 2025. Mr. McMillan was also appointed to the Audit and Finance Committee effective
1y agoHOLXHologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025Business WireHologic, Inc. (NASDAQ:HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2025 on Thursday, May 1, after the market closes. In conjunction with the release,
1y agoHOLXHologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors ConferenceBusiness WireHologic, Inc. (NASDAQ:HOLX) announced today that the Company will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Tuesday, March 4 at 11 a.m. Eastern Time (ET). The
1y agoHOLXHologic Announces FDA Clearance of Aptima SARS-CoV-2 AssayBusiness WireHologic, Inc. (NASDAQ:HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company's Aptima® SARS-CoV-2 assay, which was first granted Emergency Use
1y agoHOLXHologic Announces Financial Results for First Quarter of Fiscal 2025Business Wire– Company Reports GAAP Diluted EPS of $0.87; Non-GAAP Diluted EPS of $1.03 at High End of Guidance – – Revenue of $1,021.8 Million Increases 0.9%; Constant Currency Growth of 1.0% In-Line with Guidance – – Company
1y agoBTMD HOLX MYGN PODDBiote Announces CEO Retirement and Succession PlanBusiness WireTerry Weber Retiring as CEO and Director and Transitioning to Strategic Advisor to Company's Board of Directors Health Care Veteran Bret Christensen to Succeed Terry Weber as CEO and Director biote Corp.
1y agoHOLXNew Report Reveals Alarming Decline in Women's Cancer Testing WorldwideBusiness WireWomen's cancer testing has declined globally, according to the latest Hologic Global Women's Health Index, one of the largest collections of data on women's health and well-being. This press release features
1y agoHOLXHologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025Business Wire– Revenue of $1,021.8 Million Grows 0.9% -- -- Revenue Increases 1.0% on Constant Currency Basis, In-Line with Guidance – – GAAP and Non-GAAP EPS Expected to be Near High End of Guidance Ranges – Hologic, Inc.
1y agoHOLXHologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness WireHologic, Inc. (NASDAQ:HOLX) announced today that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 1:30 p.m. Pacific Time. The presentation and Q&A
1y agoHOLXHologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025Business WireHologic, Inc. (NASDAQ:HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2025 on Wednesday, February 5, after the market closes. In conjunction with the
1y agoHOLXHologic Completes Acquisition of Gynesonics, Inc.Business WireHologic, Inc. (NASDAQ:HOLX), a global leader in women's health, has completed its previously announced acquisition of Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the
1y agoHOLXHologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDCBusiness WireHologic, Inc. (NASDAQ:HOLX) today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — the "active ingredients" of
1y agoHOLXHologic Statement on USPSTF Draft Cervical Cancer Screening GuidelinesBusiness WireHologic, Inc., (NASDAQ:HOLX) a global leader in women's health focused on developing innovative medical technologies that effectively detect, diagnose and treat health conditions, today issued the following statement
1y agoHOLXMartin Madaus Elected to Hologic Board of DirectorsBusiness WireHologic, Inc. (NASDAQ:HOLX) announced today that Martin Madaus has been elected to the Company's Board of Directors, effective December 6, 2024. Dr. Madaus was also appointed to the Compensation Committee and the
1y agoHOLXNew Data To Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients With Minimal Risk of Distant RecurrenceBusiness WireStudy Assesses Prognostic Value of BCI Testing and Its Potential in Supporting De-escalation of Primary Adjuvant Endocrine Therapy Four new studies regarding the Breast Cancer Index (BCI) test will be presented at the
1y agoHOLXHologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse PopulationsBusiness WireLeader in Women's Health Unveils Data Underscoring Its Commitment to Reducing Bias in Breast Cancer Detection Hologic, Inc. (NASDAQ:HOLX) yesterday presented new research demonstrating the performance of its Genius
1y agoHOLXHologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024Business WireLeader in Women's Health Will Unveil Groundbreaking Innovations With a Focus on Imaging Solutions and Artificial Intelligence Hologic, Inc. (NASDAQ:HOLX) will reveal new technologies reimagining the future of breast
1y agoHOLXHologic to Webcast Presentations at Upcoming Investor ConferencesBusiness WireHologic, Inc. (NASDAQ:HOLX) announced today that the Company will present at the following upcoming investor conferences: 2024 Stephens Annual Investment Conference in Nashville, TN on Thursday, November 21st, at 10
2y agoHOLXHologic, Inc. (HOLX) Q4 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoHOLXHologic Announces Financial Results for Fourth Quarter of Fiscal 2024Business Wire– Revenue of $987.9 Million, GAAP Diluted EPS of $0.76 and Non-GAAP Diluted EPS of $1.01 – – Total Company Revenue Growth of 4.5%, or 4.2% in Constant Currency and 5.0% Organically ex. COVID-19 in Constant Currency
2y agoHOLXFDA Roundup: October 29, 2024FDA Press ReleasesToday, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA responded to objections on the agency’s final rule that removed the authorized food contact uses of most phthalates because industry abandoned these uses. The FDA evaluated the objections and concluded that they did not provide a basis for modifying the final rule. Howeve ...